Dr. Bryan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1101 Madison St
Ste 301
Seattle, WA 98104Phone+1 206-505-1101
Education & Training
University of WashingtonFellowship, Hematology and Medical Oncology, 1990 - 1993
Louisiana State University School of MedicineResidency, Internal Medicine, 1986 - 1990- Louisiana State University School of Medicine in New OrleansClass of 1986
Certifications & Licensure
WA State Medical License 1990 - 2025
LA State Medical License 1986 - 2017
Publications & Presentations
PubMed
- 78 citationsEffect of Adding Motolimod to Standard Combination Chemotherapy and Cetuximab Treatment of Patients With Squamous Cell Carcinoma of the Head and Neck: The Active8 Rand...Robert L. Ferris, Nabil F. Saba, Barbara J. Gitlitz, Robert I. Haddad, Ammar Sukari
JAMA Oncology. 2018-11-01 - 57 citationsPhase Ib Study of Immune Biomarker Modulation with Neoadjuvant Cetuximab and TLR8 Stimulation in Head and Neck Cancer to Overcome Suppressive Myeloid Signals.Gulidanna Shayan, Benjamin A. Kansy, Sandra P. Gibson, Raghvendra M. Srivastava, James Kyle Bryan
Clinical Cancer Research. 2018-01-01 - 84 citationsPhase Ib Trial of the Toll-like Receptor 8 Agonist, Motolimod (VTX-2337), Combined with Cetuximab in Patients with Recurrent or Metastatic SCCHN.Laura Q.M. Chow, Chihiro Morishima, Keith D. Eaton, Christina S. Baik, Bernardo H. L. Goulart
Clinical Cancer Research. 2017-05-15
Press Mentions
ASCO ’22 Preview: Putting Patients FirstJune 1st, 2022
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
